1 – 56 of 56
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Stakeholder Feedback on the current draft of General Recommendation N° 37 on racial discrimination in the enjoyment of the right to health (GR37) on behalf of The European Association of Health Law (EAHL) Interest Group on Supranational Biolaw
2024)(
- Other contribution › Consultation response
-
Mark
Remissyttrande: Framtidens dataskydd – Vid Skatteverket, Tullverket och Kronofogden (SOU 2023:100)
2024)(
- Other contribution › Consultation response
- 2023
-
Mark
Governing, Protecting, and Regulating the Future of Genome Editing : The Significance of ELSPI Perspectives
Slokenberga, Santa ; Minssen, Timo and Nordberg, Ana LU (2023)
- Book/Report › Anthology (editor)
-
Mark
Introduction : The significance of ELSPI perspectives in governing, protecting, and regulating the future of genome editing
2023) p.1-14(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Remissyttrande: Vissa patenträttsliga frågor
2023)(
- Other contribution › Consultation response
-
Mark
Exceptions and limitations (27 UPCA)
2023) p.109-128(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Remissyttrande: EU-läkemedelslagstiftning: Kommissionens förslag på förordning och direktiv om humanläkemedel
2023)(
- Other contribution › Consultation response
- 2022
-
Mark
Governing, protecting, and regulating the future of genome editing : The significance of ELSI perspectives
(
- Contribution to journal › Article
-
Mark
Creative Machines, Orphan Inventions: AI and the concept of inventor at the EPO
2022) p.159-180(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Balancing innovation, ‘ordre public’ and morality in human germline editing : A call for more nuanced approaches in patent law
(
- Contribution to journal › Article
-
Mark
Genome editing in humans : A survey of law, regulation and governance principles
2022)(
- Book/Report › Report
-
Mark
Governing, Protecting, and Regulating the Future of Genome Editing : The Significance of ELSPI Perspectives
(
- Contribution to journal › Scientific review
-
Mark
AICARE - AI and Automated systems and the Right to Health : Revisiting law accounting for the exploitation of users’ preferences and values
2022)(
- Contribution to conference › Poster
-
Mark
Syntetisk biologi - en hållbar lösning på klimatkrisen?
2022)(
- Contribution to conference › Poster
- 2021
-
Mark
Biobank and Biomedical Research: Responsibilities of Controllers and Processors under the EU General Data Protection Regulation
2021) p.61-89(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Big Science, Big Data, Big Innovation? : ERIC Policies on IP, Data and Technology Transfer
2021) p.65-106(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
General commentary on 'A series of scenarios developed by the World Health Organization (WHO) Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing to both test the utility of, and illustrate how to use, their governance framework'
2021)(
- Other contribution › Consultation response
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
2021)(
- Book/Report › Report
-
Mark
Sweden: Legal Response to Covid-19
2021)(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
Rules and Tools in the Battle against Superbugs - A call for integrated strategies and enhanced international collaboration to promote antimicrobial drug development
2020) p.111-136(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Trade Secrets, Big data and Artificial Intelligence Innovation: a Legal Oxymoron?
2020) p.194-220(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Implementation of the Trade Secrets Directive into National Law: Portugal and Spain
2020) p.125-150(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Remissyttrande: Utkast till Lagrådsremiss Skärpta straff för de allvarligaste formerna av immaterialrättsintrång
2020)(
- Other contribution › Consultation response
-
Mark
Remissyttrande: Inbjudan att lämna synpunkter på EU:s immaterialrättsmyndighets utkast i fråga om upprättande av en webbportal beträffande verk och andra alster som inte finns i handeln
2020)(
- Other contribution › Consultation response
-
Mark
Patents, Morality and Biomedical Innovation in Europe : Historical overview, current debates on stem cells, gene editing and AI, and de lege ferenda reflections
2020) p.243-267(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
AI, Big Data, e-Health and the Right to be Forgotten
2020) p.275-275(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Remissyttrande: Promemoria Covid-19-lag
2020)(
- Other contribution › Consultation response
-
Mark
Remissyttrande: Synpunkter rörande genomförandet av artiklarna 18-23 i EU:s nya upphovsrättsdirektiv
2020)(
- Other contribution › Consultation response
-
Mark
Remissyttrande: Uppföljning till Underlag för inhämtning av synpunkter rörande genomförandet av artikel 17 i EU:s nya upphovsrättsdirektiv
2020)(
- Other contribution › Consultation response
-
Mark
Remissyttrande: Synpunkter rörande genomförandet av artiklarna 13-16 i EU:s nya upphovsrättsdirektiv
2020)(
- Other contribution › Consultation response
-
Mark
COVID-19 Pandemic in Sweden : Measures, Policy approach and Legal and Ethical debates
(
- Contribution to journal › Article
- 2019
-
Mark
Regulating Germline Editing in Assisted Reproductive Technology : An EU Cross-disciplinary Perspective
(
- Contribution to journal › Article
-
Mark
Intellectual Property Rights in a Digital Environment : An EU Wide Mapping of Available Legislative Enforcement Measures
2019) p.281-307(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Legal method and lnterpretation in International IP law : Pluralism or Systemic Coherence
2019) p.96-96(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vi måste ta ställning till den nya gentekniken
2019) In Svenska Dagbladet, Stockholm(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Artificial Intelligence and automated decision-making in healthcare
(
- Contribution to conference › Abstract
-
Mark
Att inte debattera är inte ett alternativ
2019) In Svenska Dagbladet, Stockholm(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Legal method and interpretation in international IP law : Pluralism or systemic coherence
2019) p.96-127(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Response to Nuffield Council on Bioethics’ Genome editing and human reproduction: open call for evidence
2018)(
- Other contribution › Miscellaneous
-
Mark
Study on Legislative Measures Related to Online IPR Infringements : A Project Commissioned by the European Union Intellectual Property Office
2018)(
- Book/Report › Report
-
Mark
Cutting Edges and Weaving Threads in the Gene Editing (Я)evolution : Reconciling scientific progress with Legal, Ethical, & Social concerns
(
- Contribution to journal › Article
-
Mark
Patentability of human enhancement : From ethical dilemmas to legal (un)certainty
2018) p.54-92(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Defining Human Enhancement : Towards a Foundational Conceptual Tool for Enhancement Law
(
- Contribution to journal › Article
-
Mark
EU Design Law and 3D Printing : Finding the Right Balance in a New E-Ecosystem
2017) p.275-302(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Patenting Nanomedicine in Europe : Applying the 'medical methods exception' to emerging technologies
2017)(
- Book/Report › Book
- 2016
-
Mark
A “ray of hope” for European stem cell patents or “out of the smog into the fog”?
(
- Contribution to journal › Article
-
Mark
Medical methods and Patentability of Nanomedicine in Europe: small matter, large interrogations
2016)(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
The Evolution of the CJEU’s Case Law on Stem Cell Patents : Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation
(
- Contribution to journal › Article
-
Mark
The Impact of Broccoli II & Tomato II on European patents in conventional breeding, GMO’s and Synthetic Biology : The grand finale of a juicy patents tale?
(
- Contribution to journal › Article
-
Mark
Patentability of methods of human enhancement
(
- Contribution to journal › Article
-
Mark
A “ray of hope” for European stem cell patents or “out of the smog into the fog”?: The CJEU decision in C-364/13 and how it compares to recent US developments.(under review)
2015) In Biotechnology Law Report(
- Contribution to journal › Article
- 2014
-
Mark
Legal Challenges of Synthetic Biology: Integrating interdisciplinary elements in legal thinking
2014)(
- Contribution to conference › Abstract
- 2013
-
Mark
Nanotechnology, Human Rights, Patent law and the Global South: a brief overview
2013) p.313-332(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2012
-
Mark
Economic Justification of Patents and Exceptions to Patentability
(
- Contribution to journal › Article
- 2011
-
Mark
Nanomedicine and Nanobiothecnology Patents: the patentability exception for methods for treatment and diagnosis
2011)(
- Contribution to conference › Abstract
- 2010
-
Mark
Nanotechnology patents in Europe and the exception from patent for methods for treatment and diagnostic methods
(
- Contribution to journal › Article